Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
Yi‐Hsin Chan(Memorial Hospital of South Bend), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Yung‐Hsin Yeh(Chang Gung University), Chi‐Tai Kuo(Chang Gung Memorial Hospital), Hsin‐Fu Lee(Chang Gung Memorial Hospital), Gregory Y.H. Lip(Medical University of Białystok), Shang‐Hung Chang(Chang Gung University), Shao‐Wei Chen(Chang Gung Memorial Hospital), Ya-Chi Huang(Chang Gung Memorial Hospital), Tze‐Fan Chao(National Yang Ming Chiao Tung University)
Cited by 91
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k